JNC-8 vs. SPRINT: What Should Be The BP Target In Black Hypertensive Patients?

Dr. Jackson T. Wright, director of the Clinical Hypertension Program at UH Cleveland Medical Center, will discuss the implications of the SPRINT trial.

Presented February 25, 2016 – Cardiovascular Medicine and Surgery Grand Rounds – Spring 2016 at UH Cleveland Medical Center.

Created by

University Hospitals

Related Presenters


Jackson Wright, MD, PhD

Director, Clinical Hypertension Program, UH Case Medical Center

JACKSON T. WRIGHT, JR., MD, PHD, FACP, FASH, FAHA is Professor of Medicine and Program Director of the William T Dahms MD Clinical Research Unit at University Hospitals Case Medical Center. He is also Director of the Clinical Hypertension ...